![Yuling Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Yuling Li
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Innoforce Pharmaceuticals Co. Ltd.
![]() Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Oprichter | 01-01-2018 | - |
Corporate Officer/Principal | 01-08-2023 | - | |
Directeur/Bestuurslid | - | 01-08-2023 | |
Algemeen Directeur | - | 01-08-2023 |
Loopbaan van Yuling Li
Statistieken
Internationaal
China | 2 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Innoforce Pharmaceuticals Co. Ltd.
![]() Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Health Technology |